Greetings From an Angel Hi,
I'd like to say I feel vindicated. I like Tripp and fingers crossed I can retire off this hahahh
I was nervous a little bit there, not because I doubted the company, but because this isnt the only company I am interested in and I thought it would blow sooner. That being said, it's time for the good stuff.
Tripp has estimated global revenue for Aristotle at $2 billion, I am guessing that's for a few years from now. What really interested me is him announcing ARISTOTLE 2, which will focus on cardiovascular and neurodegenerative disease... this man is really smart to be targetting these fields that are not nearly perfected yet. To me this means that this company really has the skys limit of market cap, but will realistically hit 1 billion market cap as long as profitability trajections are as good as he implies.
Happy New Year to All, particularly those I remember like Nailz, CapeBretonGirl, and Johnny to name the ones off the top of my head. Best of luck to all, and let's make money :))